Control and freedom altogether

Control and freedom altogether. And the best experience in between. 

A1c reduction with bigger safety and lower risk of hypoglycemia. Convenience and flexibility in a single daily dose. It’s the evolution of glycemic control, but you can call it Toujeo.

Control and freedom altogether. And the best experience in between. 

A1c reduction with bigger safety and lower risk of hypoglycemia. Convenience and flexibility in a single daily dose. It’s the evolution of glycemic control, but you can call it Toujeo.

MEDICAL VISUAL AID

Efficacy in A1c reduction with less risk of hypoglycemia.

Efficiency in a daily dose. Because every control matters.

A1c reduction with less risk of hypoglycemia.

More patients reaching the goal safely.

Effective A1c reduction

Glycemic control in 6 months

Lower risk of hypoglycemia

Reduction in the risk of confirmed severe hypoglycemia and any type of hypoglycemia confirmed with Toujeo®.

• 25% reduction in severe and/or confirmed nocturnal hypoglycemia.
  
• 23% reduction in any nocturnal hypoglycemia.

Stable control in a daily dose

Less glycemic variability

Convenience and flexibility in a single daily dose

• 55% reduction in hypoglycemic events per year.

Stability in a daily dose

Toujeo presents a more stable action profile when compared to insulin DEG-U100 with uniform distribution in 24 hours in T1D patients.

• 20% intraday variability was significantly lower (20%) with Toujeo than with DEG-100 at a dose of 0.4U/kg/day.